Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: BIOAEGIS THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2023-09-21 to 2027-08-31
Current total value of award: $20000000
Description: BIOAEGIS: PLASMA GELSOLIN (PGSN), AN ABUNDANT, CIRCULATING PROTEIN MODULATES INFLAMMATION WHILE ALSO  ENHANCING HOST DEFENSES BY STIMULATING THE UPTAKE AND KILLING OF PATHOGENS. CLINICAL STUDIES HAVE  CONSISTENTLY SHOWN PGSN IS DEPLETED IN SEVERE I